hiv/aids Human immunodeficiency virus, commonly known as HIV, is a virus that targets the immune system and can lead to acquired immunodeficiency syndrome (AIDS) if left untreated. HIV can be transmitted through sexual intercourse, using needles that have been in contact with bodily fluids containing HIV, and during pregnancy, childbirth, or ...

Apr 11, 2024 · HIV, or human immunodeficiency virus, is the virus that causes acquired immune deficiency syndrome (AIDS). HIV attacks the immune system by entering and destroying CD4+ T cells, a type of white blood cell that is vital to fighting off infection.

While rates of mother to child transmission of HIV have fallen over the last decade, the Joint United Nations Programme on HIV/AIDS (UNAIDS) still estimates that as many as 1.8 million children under 15 years old worldwide were living with HIV in 2017.

Since women and girls are at particularly high risk for HIV/AIDS in many parts of the world, it is especially important to have an effective, desirable vaginal microbicide as an HIV prevention tool that women can control. Read more about microbicides. Prevention of Perinatal Transmission

Jun 19, 2018 · HIV/AIDS. Prevention. Pre-exposure Prophylaxis (PrEP) Treatment as Prevention. Microbicides. Prevention of ...

Research Areas HIV/AIDS Treatment Future Directions for HIV Treatment Research A major goal of NIAID-supported research on HIV treatment today is to develop long-acting therapies that—unlike current antiretrovirals, which require daily dosing—could be taken only once a week, once a month, or even less often.

Jan 3, 2025 · Learn more about the HIV/AIDS clinical trials networks and the network refinement process with the resources and information available on this site. The following resources on HIV scientific and operational priorities published in the NIAID Now blog may be of particular interest.

Jan 26, 2024 · The National Institutes of Health (NIH) HIV Reagent Program (formerly NIH AIDS Reagent Program) has been a central resource for a wide range of infectious agents and pathogens, biological materials, and chemicals for distribution to the scientific community. The HIV Reagent Program acquires, develops, authenticates and produces high quality, …

Jan 2, 2025 · The Division of AIDS (DAIDS) was formed in 1986 to develop and implement the national research agenda to address the HIV/AIDS epidemic. Toward that end, the division supports a global research portfolio to advance biological knowledge of HIV/AIDS, its related co-infections, and co-morbidities.

Feb 9, 2016 · Harm reduction strategies aim to lessen harms associated with drug use and related behaviors that increase the risk of HIV infection.